Latest News

Karyopharm seeks FDA approval for drug in highly refractory blood cancer

Drugmaker applies for selinexor in penta-refractory multiple myeloma, in which bluebird’s bb2121 has also shown efficacy.

Source link

Related posts

MSU professor wins prestigious award for brain research


Medical News Today: What are the best lower chest exercises?


Lack of sexual activity in older adults linked to health problems


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy